Salute e Benessere
/C O R R E C T I O N -- Suanfarma/
With a career spanning more than 30 years, Pere has held technical and strategic executive positions at leading pharmaceutical companies such as , , and . His experience ranges from technical and operational roles to executive positions such as and .
Most recently, Pere played a key role in the , positioning its chemical division as a global benchmark. Under his leadership, the company was recognized as at the , one of the industry's most prestigious honors.
This appointment aligns with Suanfarma's long-term strategic vision. , interim CEO since October 2024 , will ensure a smooth transition and will remain with the company as :
Pere's arrival brings decisive momentum to Suanfarma's growth journey. His focus on operational excellence, advanced CDMO capabilities, and strong strategic partnerships will guide the company through its next phase with the following objectives:
In the words of ,
Founded in 1993, Suanfarma is a B2B partner in the life sciences sector, committed to health and innovation through the sustainable development, manufacturing, and distribution of high-quality pharmaceutical ingredients. With presence in over 70 countries, it has been part of the healthcare-focused investment firm Archimed since 2021.
Photo: https://mma.prnewswire.com/media/2669173/Suanfarma.jpg
Logo: https://mma.prnewswire.com/media/2666505/SUANFARMA_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/pere-mane-appointed-as-new-ceo-of-suanfarma-302433514.html